Skip to main content

Peer Review reports

From: A randomized placebo-controlled trial of delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis from East Asia and other countries

Original Submission
27 Jul 2017 Submitted Original manuscript
20 Oct 2017 Reviewed Reviewer Report - Anthony Traboulsee
5 Nov 2017 Reviewed Reviewer Report - Roberta Lanzillo
8 Dec 2017 Author responded Author comments - Takahiko Saida
Resubmission - Version 2
8 Dec 2017 Submitted Manuscript version 2
3 May 2018 Reviewed Reviewer Report - Anthony Traboulsee
3 May 2018 Reviewed Reviewer Report - Roberta Lanzillo
15 May 2018 Reviewed Reviewer Report - Emanuele D'Amico
18 Jun 2018 Author responded Author comments - Takahiko Saida
Resubmission - Version 3
18 Jun 2018 Submitted Manuscript version 3
13 Jul 2018 Reviewed Reviewer Report - Emanuele D'Amico
16 Aug 2018 Author responded Author comments - Takahiko Saida
Resubmission - Version 4
16 Aug 2018 Submitted Manuscript version 4
1 Nov 2018 Author responded Author comments - Takahiko Saida
Resubmission - Version 5
1 Nov 2018 Submitted Manuscript version 5
5 Dec 2018 Author responded Author comments - Takahiko Saida
Resubmission - Version 6
5 Dec 2018 Submitted Manuscript version 6
Publishing
6 Dec 2018 Editorially accepted
7 Jan 2019 Article published 10.1186/s12883-018-1220-3

You can find further information about peer review here.

Back to article page